Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Candel Therapeutics (CADL) Other Gross PP&E Adjustments (2020 - 2025)

Candel Therapeutics' Other Gross PP&E Adjustments history spans 4 years, with the latest figure at $3.3 million for Q4 2023.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 8.89% to $3.3 million in Q4 2023 year-over-year; TTM through Dec 2023 was $3.3 million, a 8.89% decrease, with the full-year FY2023 number at $3.3 million, down 8.89% from a year prior.
  • Other Gross PP&E Adjustments hit $3.3 million in Q4 2023 for Candel Therapeutics, down from $4.2 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CADL hit a ceiling of $4.3 million in Q2 2023 and a floor of $2.3 million in Q4 2020.
  • Historically, Other Gross PP&E Adjustments has averaged $3.6 million across 4 years, with a median of $3.7 million in 2021.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 47.98% in 2021 and later decreased 9.06% in 2022.
  • Tracing CADL's Other Gross PP&E Adjustments over 4 years: stood at $2.3 million in 2020, then surged by 47.98% to $3.4 million in 2021, then rose by 7.9% to $3.6 million in 2022, then dropped by 8.89% to $3.3 million in 2023.
  • Business Quant data shows Other Gross PP&E Adjustments for CADL at $3.3 million in Q4 2023, $4.2 million in Q3 2023, and $4.3 million in Q2 2023.